Literature DB >> 27369072

LXR agonist rescued the deficit in the proliferation of the cerebellar granule cells induced by dexamethasone.

Xuting Bian1, Hongyu Zhong1, Fen Li1, Yulong Cai1, Xin Li1, Lian Wang1, Xiaotang Fan2.   

Abstract

Dexamethasone (DEX) exposure during early postnatal life produces permanent neuromotor and intellectual deficits and stunts cerebellar growth. The liver X receptor (LXR) plays important roles in CNS development. However, the effects of LXR on the DEX-mediated impairment of cerebellar development remain undetermined. Thus, mice were pretreated with LXR agonist TO901317 (TO) and were later exposed to DEX to evaluate its protective effects on DEX-mediated deficit during cerebellar development. The results showed that an acute exposure of DEX on postnatal day 7 resulted in a significant impairment in cerebellar development and decreased the proliferation of granule neuron precursors in the external granule layer of cerebellum. This effect was attenuated by pretreatment with TO. We further found that the decrease in the proliferation caused by DEX occurred via up-regulation of glucocorticoid receptor and p27kip1, which could be partially prevented by LXR agonist pretreatment. Overall, our results suggest that LXR agonist pretreatment could protect against DEX-induced deficits in cerebellar development in postnatal mice and may thus be perspective recruited to counteract such GC side effects.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebellum; Development; Dexamethasone; LXR; Proliferation

Mesh:

Substances:

Year:  2016        PMID: 27369072     DOI: 10.1016/j.bbrc.2016.06.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Absence of estrogen receptor beta leads to abnormal adipogenesis during early tendon healing by an up-regulation of PPARγ signalling.

Authors:  Xuting Bian; Tianyao Liu; Mei Zhou; Gang He; Yuanyuan Ma; Youxing Shi; Yunjiao Wang; Hong Tang; Xia Kang; Mingyu Yang; Jan-Åke Gustafsson; Xiaotang Fan; Kanglai Tang
Journal:  J Cell Mol Med       Date:  2019-09-02       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.